SABA, Laura

SABA, Laura  

SCIENZE CLINICHE E BIOLOGICHE  

Mostra records
Risultati 1 - 20 di 24 (tempo di esecuzione: 0.044 secondi).
Titolo Data di pubblicazione Autore(i) File
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. 2019 Calabrese A, Basile V, Puglisi S, Perotti P, Pia A, Saba L, Berchialla P, Porpiglia F, Veltri A, Volante M, Reimondo G, Berruti A, Terzolo M.
Albumin/Mitotane Interaction Affects Drug Activity in Adrenocortical Carcinoma Cells: Smoke and Mirrors on Mitotane Effect with Possible Implications for Patients’ Management 2023 Aurora Schiavon; Laura SABA; Gianluca Catucci; Jessica Petiti; Soraya Puglisi; Chiara Borin; Giuseppe Matteo REIMONDO; Gianfranco Gilardi; Claudia Giachino; Massimo Terzolo; MARCO LO IACONO
Cortisol secretion, bone health, and bone loss: a cross-sectional and prospective study in normal nonosteoporotic women in the early postmenopausal period. 2012 Osella G; Ventura M; Ardito A; Allasino B; Termine A; Saba L; Vitetta R; Terzolo M; Angeli A.
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells 2018 Germano, Antonina; Saba, Laura; De Francia, Silvia; Rapa, Ida; Perotti, Paola; Berruti, Alfredo; Volante, Marco; Terzolo, Massimo*
Differential expression of determinants of glucocorticoid sensitivity in androgen-dependent and androgen-independent human prostate cancer cell lines 2009 Dovio A; Sartori ML; De Francia S; Mussino S; Perotti P; Saba L; Abbadessa G; Racca S; Angeli A.
Differential responses of serum and salivary interleukin-6 to acute strenuous exercise 2005 MINETTO M; RAINOLDI A; GAZZONI M; TERZOLO M; BORRIONE P; TERMINE A; SABA L; DOVIO A; ANGELI A; PACCOTTI P
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 2017 Reimondo, Giuseppe Matteo; Puglisi, Soraya; Zaggia, Barbara; Basile, Vittoria; Saba, Laura; Perotti, Paola Carla Giuseppina; DE FRANCIA, Silvia; Volante, Marco; Maria Chiara Zatelli, ; Salvatore, Cannavò; Terzolo, Massimo
High-dose glucocorticoids increase serum levels of soluble IL-6 receptor alpha and its ratio to soluble gp130: an additional mechanism for early increased bone resorption 2006 A. DOVIO; L. PERAZZOLO; L. SABA; A. TERMINE; M. CAPOBIANCO; A. BERTOLOTTO; A. ANGELI
Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profile 2007 A. DOVIO; B. ALLASINO; E. PALMAS; M. VENTURA; A. PIA; L. SABA; E. AROASIO; M. TERZOLO; A. ANGELI
Influence of the sample collection method on salivary interleukin-6 levels in resting and exercise-stimulated conditions. 2007 Minetto M.A.; Gazzoni M.; Lanfranco F.; Baldi M.; Saba L.; Pedrola R.; Rainoldi A.
Influence of the sample collection method on salivary interleukin-6 levels in resting and post-exercise conditions 2007 MINETTO M.A; GAZZONI M; LANFRANCO F; BALDI M; SABA L; PEDROLA R; KOMI P.V; RAINOLDI A
Influenza del metodo di raccolta salivare sui livelli di Interleukina-6 a riposo e dopo esercizio 2007 Minetto A.; Gazzoni M; Lanfranco F; Baldi M; Saba L; Pedrola R; Rainoldi A
Interleukin-6 response to isokinetic exercise in elite athletes: relationships to adrenocortical function and to mechanical and myoelectric fatigue 2006 Minetto M.; Rainoldi A; Gazzoni M.; Ganzit G.P.; Saba L.; Paccotti P.
Involvement of 27-Hydroxycholesterol in Mitotane Action on Adrenocortical Carcinoma 2020 Germano, Antonina; Rossin, Daniela; Leoni, Valerio; Iaia, Noemi; Saba, Laura; Basile, Vittoria; Puglisi, Soraya; Caccia, Claudio; Poli, Giuseppe; Biasi, Fiorella; Terzolo, Massimo
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma 2020 Puglisi S.; Calabrese A.; Basile V.; Ceccato F.; Scaroni C.; Altieri B.; Casa S.D.; Loli P.; Pivonello R.; De Martino M.C.; Canu L.; Russo M.; Badalamenti G.; Torlontano M.; Stigliano A.; Ferrau F.; Arnaldi G.; Saba L.; Quirino A.; Perotti P.; Berchialla P.; Terzolo M.
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 2019 Puglisi S, Calabrese A, Basile V, Ceccato F, Scaroni C, Simeoli C, Torlontano M, Cannavò S, Arnaldi G, Stigliano A, Malandrino P, Saba L, Altieri B, Della Casa S, Perotti P, Berchialla P, De Filpo G, Canu L, Loli P, Reimondo G, Terzolo M.
Molecular mechanisms of mitotane action in adrenocortical cancer based on in vitro studies 2021 Lo Iacono M.; Puglisi S.; Perotti P.; Saba L.; Petiti J.; Giachino C.; Reimondo G.; Terzolo M.
Natural killer cell activity and sensitivity to positive and negative modulation in uncomplicated obese subjects: relationships to leptin and diet composition 2004 A. DOVIO; V. CARAMELLO; R.G. MASERA; M.L. SARTORI; L. SABA; M. TINIVELLA; P. PROLO; A. TERMINE; P. AVAGNINA; A. ANGELI
Neuroendocrine immunity in patients with Alzheimer's disease: toward translational epigenetics 2007 CHIAPPELLI F ;PROLO P ;D CAJULIS K ;ANGELI A ;DOVIO A ;PEROTTI P ;PAUTASSO M ;LUISA SARTORI M ;SABA L ;MUSSINO S ;FRACCALINI T ;FANTO F ;MANFRINI E ;MOCELLINI C ;GABRIELLA ROSSO M ;GRASSO E
Osteoprotegerina e RANKL solubile in relazione al danno osseo e vascolare nella sclerosi sistemica 2008 R. Carignola; A. Dovio; V. Data; G. Calzolari; B. Allasino; L. Saba; A. Angeli.